Focus: Hoya Surgical Optics is a Singapore-Washington headquartered biotechnology company specializing in the development and manufacturing of advanced intraocular lenses (IOLs) for ophthalmology. With 5,000+ employees and public company status, it operates as a scaled medical device manufacturer within the ophthalmology segment.
Profile data last refreshed 16h ago · AI intelligence enriched 2w ago
Best suited for manufacturing, quality, or regulatory professionals seeking stable ophthalmology device careers; less attractive for those seeking pipeline-driven research growth or clinical development experience.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Hoya Surgical Optics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Hoya Surgical Optics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles